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The three-pore model of peritoneal fluid transport predicts
that once the osmotic gradient has dissipated, fluid
reabsorption will be due to a combination of small-pore
reabsorption driven by the intravascular oncotic pressure,
and an underlying disappearance of fluid from the cavity by
lymphatic drainage. Our study measured fluid transport by
these pathways in the presence and absence of an osmotic
gradient. Paired hypertonic and standard glucose-dwell
studies were performed using radio-iodinated serum albumin
as an intraperitoneal volume marker and changes in
intraperitoneal sodium mass to determine small-pore versus
transcellular fluid transport. Disappearance of iodinated
albumin was considered to indicate lymphatic drainage.
Variability in transcellular ultrafiltration was largely explained
by the rate of small-solute transport across the membrane. In
the absence of an osmotic gradient, fluid reabsorption
occurred via the small-pore pathway, the rate being
proportional to the small-solute transport characteristics of
the membrane. In most cases, fluid removal from the
peritoneal cavity by this pathway was faster than by
lymphatic drainage. Our study shows that the three-pore
model describes the pathways of peritoneal fluid transport
well. In the presence of high solute transport, poor
transcellular ultrafiltration was due to loss of the osmotic
gradient and an enhanced small-pore reabsorption rate after
this gradient dissipated.
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Fluid transport across the peritoneal membrane is best
described in theoretical terms by the three-pore model as
originally proposed by Rippe.1 This model identifies four
potential pathways, a transcellular, water-exclusive pore
system, now clearly identified as endothelial aquaporins;2,3
an intercellular population of small pores, responsible for
diffusive transport of small solutes, including water;4,5 large
pores, identified as the pathway for macromolecular leakage
into the peritoneal cavity driven by hydrostatic pressure
gradients; and a lymphatic route responsible for a proportion
of fluid, solute, and macromolecular reabsorption.
It is possible, using the combination of an intra-peritoneal
volume marker and measured concentrations of low-
molecular-weight solutes, especially sodium, to estimate the
proportion of fluid transport occurring via these pathways at
different time points during a typical dwell.6 Using this
approach, during hypertonic (3.86% glucose) standard
peritoneal permeability analysis tests, the relative compo-
nents of fluid transport during the early stages of the dwell,
especially the first 60 min, have been found to agree closely
with the predictions of the model.7 Small pores contribute a
little over 50% of the total ultrafiltration, with a between-
patient rate variability that is proportional to the membrane
transport characteristics; as predicted, aquaporin fluid
transport is proportional to osmotic gradient.
The three-pore model also predicts that following osmotic
equilibration, reabsorption of fluid will occur via two
pathways, the lymphatics and the small pores due to oncotic
pressure gradient. Agreement between empirical and theore-
tical data from the point of equilibration of the osmotic
gradient, especially the subsequent net reabsorption phase of
the dwell, is less clear. This is partly due to previous studies
having utilized relatively short (4 h) exchanges with hyper-
tonic solutions that are not best designed to interrogate the
reabsorption phase of the cycle. Alternatively, there may be
difficulties with the type of volume marker used and
interpretation of whether its disappearance reflects effective
lymphatic absorption rates or small-pore fluid transport. The
purpose of this study was determine the pathways of fluid
transport under high and low glucose concentrations, the
latter allowing examination of the reabsorption phase as the
osmotic gradient dissipates rapidly. A different volume
marker (125I-albumin) was used to compare and contrast
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findings with previous studies. Finally, as the method for
determining aquaporin versus small-pore fluid transport
necessitates the use of a correction factor for the diffusion of
sodium, the impact of using different small-solute mass
transfer area coefficients (MTACs) for creatinine and urate
was also assessed.
RESULTS
Patient demographics
Eight stable male peritoneal dialysis patients were studied;
their mean age was 55 years and the average time on
peritoneal dialysis therapy was 21 months. Solute transport
status ranged from 0.542 to 0.801, with a mean of 0.69 as
determined by the dialysate to plasma creatinine ratio at 4 h
and body surface area from 1.73 to 2.28 m2.
Intraperitoneal volume curves for fluid pathways
The net changes in intraperitoneal volume and the
components of fluid transport via aquaporin, small-pore,
and effective lymphatic reabsorption are shown in Figures 1
and 2 for 3.86 and 1.36% glucose concentration, respectively.
Ultrafiltration via different pathways. The average rates of
ultrafiltration at different time periods during the 3.86%
dwells, including the different pore pathways, are summar-
ized in Table 1 and Figure 1. It can be seen that these are time
dependent, with the proportion via small pores being 55–70%
depending on the method of correction for sodium diffusion.
As expected, failure to correct leads to a higher proportion
being assigned to small pores; the correction resulted in
increased estimates for transcellular ultrafiltration, and this
was greater when using urate in the early part of the exchange
and when using creatinine over the whole 240 min.
During the first part of the 3.86% dwell (30–60 min), the
rate of ultrafiltration via the small pores positively correlated
with solute transport, whereas transcellular ultrafiltration
more strongly negatively correlated (Figure 3a). In contrast,
average small-pore ultrafiltration over the whole dwell did
not correlate with solute transport, whereas variability in
transcellular fluid transport was strongly negatively correlated
to small-solute transport rate (Figure 3b).
Reabsorption via different pathways. This is summarized
in Figure 2. It can be seen that in the latter part of the dwell,
significant fluid reabsorption occurs via the small-pore
pathway, typically 1.34 (s.d.±0.97) ml min1. The rate of
this fluid reabsorption, calculated from the individual
gradients between 120, 180, and 240 min, strongly correlated
to solute transport rate (R¼ 0.78, Po0.01), indicating that
patients with high transport absorbed fluid more rapidly
(Figure 4). This correlation was observed whether or not the
small-pore transport was corrected for diffusion, as effectively
very little fluid reabsorption occurred via the transcellular
pores, estimates being 0.31, 0.17, and 0.29 ml min1 un-
corrected or corrected for creatinine or urate diffusion,
respectively.
The fluid reabsorption estimated to be via lymphatics (see
Figures 1 and 2) was linear with time for both glucose
concentrations, the mean of the five estimates made in each
patient being 0.65 ml min1 (s.e.m.±0.19) for the 1.36%
and 0.52 (±0.22) ml min1 for the 3.86% dwells. There
was a weak but significant correlation between the rate of
lymphatic absorption and solute transport for the 1.36%
dwells, R¼ 0.42, Po0.05, which was less significant in the
3.86% dwells, R¼ 0.22, P¼ 0.05.
DISCUSSION
These data are broadly supportive of the three-pore model of
peritoneal fluid transport; they confirm previous observa-
tions of the relative fluid transport via the different proposed
pathways in the ultrafiltration phase of a 3.86% exchange
using a different intraperitoneal volume marker, and show
convincingly for the first time the relative fluid reabsorption
via small pores versus lymphatics. They also show that the
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Figure 1 | Changes in net intraperitoneal volume (J) attributable
to small-pore (E), transcellular pore (K), and effective
lymphatic (- - -) pathways using 3.86% glucose solution.
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Figure 2 | Changes in net intraperitoneal volume (J) attributable
to small-pore (E), transcellular pore (K), and effective
lymphatic (- - -) pathways using 1.36% glucose solution.
Kidney International (2008) 73, 1048–1053 1049
RB Asghar and SJ Davies: Pathways of peritoneal reabsorption o r i g i n a l a r t i c l e
influence of transport status on ultrafiltration is complex;
while high solute transport is associated with increased
ultrafiltration via small pores in the early stages of the
exchange, this benefit is markedly outweighed by the negative
effect on aquaporin fluid transport and the increased fluid
reabsorption via small pores that occurs in longer dwells or
when the osmotic gradient has dissipated.
The values obtained for total and relative ultrafiltration via
the small-pore and aquaporin pathways during the first part
of the 3.86% exchange were similar to those found previously
using either dextran as an intraperitoneal volume marker or
using simple volume drainage using the fast-fast peritoneal
equilibration test.6–8 As would be predicted from theoretical
modeling, correction for diffusion of sodium, using either the
MTAC for urate or creatinine, resulted in a reduction in the
proportion of fluid estimated to pass via the small pores.9
There has been debate as to which, if any, solute should be
used for this correction. Close inspection of our data shows
that the influence of correction differs according to the stage
of the dwell, with urate resulting in a greater effect in the
early part of the dwell, whereas using creatinine correction
this increases as the dwell progresses. This difference is likely
to reflect the relative difficulty we had in fitting urate
diffusion–equilibration curves when calculating the MTAC
for this solute, which did not always reach equilibrium
during 4 h, probably due to the effects of charge on this
molecule (Gibbs–Donnan effect). For the same reason, when
urate was used for correction in the 1.36% glucose exchanges,
it estimated that more fluid reabsorption was occurring via
the aquaporins in the last part of the dwell compared with
Table 1 | Mean ultrafiltration rates over 30, 60, and 240 min of 3.86% glucose exchange via different pathways with or without
correction for diffusion
Mean ultrafiltration rate (ml min1) No correction for diffusion Corrected using MTACurate Corrected using MTACcreatinine
Total
0–30 min 7.28 (1.9) — —
0–60 min 6.15 (1.58) — —
0–240 min 2.23 (1.0) — —
Small pores
0–30 min 4.6 (1.5) 63% 3.9 (2.0) 53% 4.23 (1.3) 58%
0–60 min 3.7 (1.1) 60% 3.36 (1.3) 54% 3.45 (1.03) 56%
0–240 min 1.67 (0.7) 75% 1.57 (0.7) 71% 1.51 (0.67) 68%
Transcellular pores
0–30 min 2.67 (0.75) 37% 3.35 (2.2) 46% 3.05 (1.3) 42%
0–60 min 2.4 (0.84) 39% 2.78 (1.7) 45% 2.69 (1.2) 44%
0–240 min 0.55 (0.41) 24% 0.65 (0.64) 29% 0.71 (0.59) 32%
MTAC, mass transfer area coefficient.
Percentages=proportion of total ultrafiltration.
The bold italicized percentages equal the proportion of the total ultrafiltration via their pathway.
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Figure 3 | Relationship of small-pore and transcellular pore
ultrafiltration to transport status. Variability in ultrafiltration rate at
(a) 30–60 min and at (b) 240 min attributable to solute transport
characteristics of the membrane via the small-pore (&) and
transcellular (K) pathways using 3.86% glucose.
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Figure 4 | Variability in the rate of fluid reabsorption
(120–240 min) via small pores using 1.36% glucose solution.
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estimation using creatinine for correction. It can be
concluded that creatinine is preferable to urate as a
correction factor, although it is likely that both lead to
over-correction, as MTAC for sodium is probably much
lower, at 4–6 ml min1. This remains controversial, as
assumptions are made in estimating the Gibbs–Donnan
effect, but for practical purposes, as suggested by La Milia6 in
the fast-fast peritoneal equilibration test, for short exchanges
(1 h or less) the effect of diffusion can effectively be ignored.
The observation that small-pore fluid transport correlated
positively with transport status in the first hour of the dwell,
is in agreement with studies using dextran as an intraper-
itoneal volume marker.7 This is in keeping with predictions
of the three-pore model, as solute transport is effectively a
measure of the small pore area in contact with dialysis fluid,
and so patients with high transport status have a greater
small pore area available for ultrafiltration via this pathway.
This positive association of small-pore fluid transport and
transport status was far outweighed by the negative
association with transcellular fluid transport in the early
part of the dwell. These two opposite effects of solute
transport on ultrafiltration via different pathways early in the
dwell might explain why no relationship with overall
ultrafiltration was observed when using less complex models
of membrane function.10 This also confirms previous
findings that by far osmotic gradient is the most important
determinant of transcellular fluid transport. Indeed, it
suggests that whereas small-pore fluid transport appears to
be, to some extent, pore area-limited, this not the case for
transcellular transport, indicating that there is relative
redundancy in this pore system. This might also explain
why a 50% reduction of aquaporin expression in hybrid
knockout mice does not lead to a proportionate reduction in
ultrafiltration,3 and why aquaporin staining is not obviously
reduced in severe ultrafiltration failure.11 The reduced free
water transport observed in severe ultrafiltration failure
appears to be part of a more general reduction in
ultrafiltration due to reduced osmotic conductance of the
membrane affecting both pathways.8 While comparing
patients with and without ultrafiltration was not the purpose
of this study, three of the subjects did have poor ultrafiltra-
tion as defined by net fluid removal on the 3.86% exchange
o400 ml at 4 h. They had significantly higher small-solute
transport (MTACcreatinine 11.4±1.6 vs 7.3±1.9 ml min
1,
P¼ 0.02), which entirely explained their lower transcellular
transport at 60 min. At 240 min, it was net ultrafiltration via
the small-pore pathway that differed the most (210±33 vs
454±131 ml, P¼ 0.02). In contrast to previous studies
showing that small-pore fluid transport remains linear
between 2 and 4 h of a 3.86% dwell,7 a plateau or even a
reversal of flow occurred toward the end of the dwell in the
present study. This explained the relatively poor net small-
pore ultrafiltration observed in the patients with ultrafiltra-
tion failure, whose peak ultrafiltration occurred between 120
and 180 min, whereas in the remaining subjects this had not
occurred by 240 min.
This reversal of small-pore flow was much more easily
seen in the 1.36% exchanges, where the rate was found to be
proportional to the transport status or small pore area. The
three-pore model predicts that once the osmotic gradient has
dissipated, that net fluid reabsorption will occur via two
pathways, the small pores, due to the oncotic pressure
gradient, and the lymphatic pathways. Although these two
pathways have long been acknowledged, there is considerable
debate as to their relative importance.12,13 In this study, fluid
reabsorption via both pathways was proportional to the
transport status, although this relationship was relatively
stronger for that occurring via small pores. An association
between transport status and effective lymphatic absorption
rate has been found previously.14 Bigger membranes are likely
to have more lymphatics as well as more small pores, and so
this might in part represent coupling due to size, but the
present study also suggests that the absolute rate of fluid
reabsorption is greater via small pores than via lymphatics,
and that it is the between patient variability in small-pore
reabsorption that results in the clinical problems associated
with high transport. The relative contributions of lymphatic
versus trans-capillary fluid reabsorption observed here are
also compatible with predictions made from the distributed
model for fluid reabsorption.15 This model considers the
membrane as a three-dimensional structure with capillaries
embedded spatially within it.16 It is possible to envisage that
capillaries at different depths or at different points in their
length, with different blood flows are associated with either
ultrafiltration or back flow, as hypothesized by Ronco17–19
and described here, via the small-pore pathway.
Part of the controversy over the relative importance of
lymphatic verses small-pore pathways in fluid reabsorption
relates to the methodological difficulties in measurement.
Effective lymphatic absorption is inferred from disappearance
of the large-molecular-weight molecules, although it is
recognized that these may adsorb onto the peritoneal
membrane and its interstitium, especially in the first few
minutes of the dwell,20 and it must be recognized that only a
fraction of the marker disappearance directly enters the
lymphatics. The estimate of ‘lymphatic’ flow in this study,
using radio-iodinated serum albumin, was certainly less than
that observed using dextran;7,8,21 this was due to a relatively
high recovery of radio-iodinated serum albumin. Whereas
poor recoveries will lead to an overestimate of this pathway, it
is difficult to see how the opposite might be occurring. It is
possible, however, that an overestimate of fluid reabsorption
by the lymphatics might lead to an underestimate of small-
pore reabsorption in the latter part of a 3.86% dwell.
This study has emphasized the importance of small-pore
fluid reabsorption as a cause of poor ultrafiltration and
potentially frank ultrafiltration failure. One of the disadvan-
tages of membrane function tests that concentrate on the
early components of ultrafiltration, such as the peritoneal
equilibration test (PET), mini-PETs, and standard peritoneal
permeability analysis, is that they draw attention away from
this aspect of poor net ultrafiltration. Fortunately there is
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now a solution to this problem in the form of icodextrin;
indeed, the observation that icodextrin, by counterbalancing
the oncotic pressure gradient responsible for drawing fluid
back across the small pores, leading to a relative clinical
benefit that is greatest in high-transport patients, strongly
supports the clinical importance of this pathway compared
with lymphatics.22 The recent finding that a glucose–icodex-
trin combination fluid results in additive effects lends further
support to this mechanism23 and underpins the value of
mathematical modeling of the membrane in solution design
that the present study has further validated.
MATERIALS AND METHODS
Study design and experimental protocol
Eight stable patients established on peritoneal dialysis with no recent
episodes of peritonitis, but varying membrane function, were
recruited. Paired, 240-min dwell studies were performed using either
glucose 3.86% solution (Physioneals; Baxter Healthcare, Thetford,
UK) to investigate the early phase of osmotically driven ultrafiltra-
tion, or glucose 1.36% to examine the re-absorptive phase of fluid
transport.
Each test exchange contained 125radio-iodinated serum albumin
(99% labeled, dose 90 kBq) as an intraperitoneal volume marker.24
The test fluid was primed with 2 ml of 20% albumin to minimize
tracer adhesion to the surrounding plastic and connections. During
test exchange, frequent dialysate samples were drawn for measure-
ment of solutes, including sodium, urea, urate, creatinine, and
glucose; blood samples for solute analysis were taken at the
beginning, at 60 min, and on completion of the 4-h test exchange.
A subsequent shortened peritoneal exchange (rinse exchange),
duration 45 min, was performed with 2 l of 1.36% glucose, normal
pH, bicarbonate/lactate solution (Physioneal; Baxter Healthcare) to
calculate peritoneal residual volume.24 The study was approved by
the local ethics committee after external peer review and patients
gave written informed consent.
Analytical methods
Concentrations of solutes in dialysate and plasma were determined
by a combination of enzymatic assay methods using an automated
discrete random access analyser (DAX 72; Bayer Instruments,
Basingstoke, UK), while sodium level was measured with the same
equipment using the indirect ion electrode method, which, for
dialysate, gave results equivalent to that of flame photometry in our
laboratory. Plasma sodium was corrected for the Gibbs–Donnan
effect, with a correction factor of 0.96. Dialysate creatinine levels
were corrected for the effect of dialysate glucose concentration.
Radioactivity was determined from triplicate samples using an
Intertechnique Gamma counter. Background radiation was ac-
counted for and the percentage error between each sample was
within the order of 1 to 1.5%. Consistent reproducibility was
demonstrated in our tracer technique, with recovery of isotope on
completion of the peritoneal exchange averaging at 86.3%
(s.d.±7.2)24,25 calibrated against a pre-prepared standard for each
individual experiment.
Calculations
Calculation of intraperitoneal volume profiles. The mathe-
matical principles developed by Lindholm et al.24 were employed to
determine the apparent (Va(t)) and actual (Vd(t)) intraperitoneal
volumes during the course of the peritoneal exchange. Calculation
of Va(t) (Equation (1)) assumes no loss of isotope from the
peritoneal cavity, and will therefore overestimate peritoneal volume;
this volume can be determined by measuring the radioactivity
within the dialysate sample at any time point, Cr(t), the initial
instilled dialysate volume, V0, and the initial radioactivity count, C0.
Significant volumes of fluid are drawn during the course of the
peritoneal exchange for purposes of analysis and these were
accounted for within the calculations:24
VaðtÞ:CrðtÞ ¼ V0C0 ð1Þ
The calculation of the actual peritoneal volume, Vd(t) (Equation
(2)), uses first-order kinetics for the disappearance of the tracer
molecule from the peritoneal cavity:
VdðtÞ ¼
VaðtÞð1  ðVaðTÞ  ðVout þ VresÞÞtÞ
ðVaðTÞÞ T
ð2Þ
Where Vres is the residual volume (estimated from the ‘rinse
exchange’ following the ‘test exchange’). Va(T) and Vout represent the
final apparent volume and the final drained volume respectively and
T is the duration of the ‘test exchange’.
The net ultrafiltration of fluid was determined by subtracting the
initial instilled fluid volume at the start of the peritoneal exchange
from the calculated Vd, for purposes of standardization and to allow
comparison of data, these values were normalized to an initial
instilled volume of 2 l. The differences between the two calculated
volumes, Va(t) and Vd(t), during the course of the exchange exhibited
a linear relationship and the calculated gradient of this slope
represented the effective ‘lymphatic’ route reabsorption of fluid (L).
The best-fit exponential relationship as described by Rippe et al.
(Equation (3))26,27 was employed to describe individual volume
profiles with greater precision. The best-fit volume at any time
point, V(t), follows an exponential relationship, where V0 defines the
initial instilled peritoneal volume, while a1, a2, and k are coefficients
defining this relationship. As repeat studies were conducted in each
individual, it was possible to use the paired glucose data to
determine a common value for a2, for each individual, which was
then incorporated into the unweighted least-squares method to
determine the best-fit volume profiles.
VðtÞ ¼ V0 þ a1ð1  ektÞ  a2t ð3Þ
Calculation of mass transfer area coefficient. The simplified
Garred equation (see Equation (4)) was used to calculate the MTAC
for solutes,28 using the intraperitoneal volume (best-fit calculated
volume, Vt) and dialysate (Dt) solute measurements at 120 min
(min), as diffusive transport is maximal during this phase of the
exchange.
MTAC ¼Vt
t
ln
ðV0ðP  D0ÞÞ
ðVtðP  DtÞÞ
ð4Þ
Calculation of small and transcellular fluid transport. The
relative proportion of fluid transport via the small intercellular
and transcellular pores was determined by the method of La Milia.6
This is based on the principle that fluid transport via the small
pores is accompanied by solute, for example, sodium, whereas
transcellular fluid transport is water-selective. By knowing the
intraperitoneal mass of sodium removed at any time point
from Equation (5), small-pore fluid transport can be determined
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from Equation (6):
Naþ Removed ðtÞ ¼ ðVdðtÞ½NaþðtÞÞ  ðVIN½NaþINÞ ð5Þ
Fluid transport small pores ðmlÞ ¼ Na
þ
Removed ðtÞ1000
½plasma Naþ ð6Þ
The diffusive component of sodium transport was corrected for using
either the MTAC for creatinine or urate, or was left uncorrected (see
text of results section). Transcellular fluid removal was calculated by
subtracting small-pore fluid transport from the total.
Statistical analysis
Data are presented as mean values±s.d. Linear regression was
performed using Pearson correlation coefficient.
ACKNOWLEDGMENTS
Kidney Research UK was the primary source of funding for this work;
additional funding was obtained from the North Staffordshire
Medical Institute that also supported the Renal Clinical Research
Facility.
REFERENCES
1. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993;
13(Suppl 2): S35–S38.
2. Yang B, Folkesson HG, Yang J et al. Reduced osmotic water permeability
of the peritoneal barrier in aquaporin-1 knockout mice. Am J Physiol 1999;
276: C76–C81.
3. Ni J, Verbavatz JM, Rippe A et al. Aquaporin-1 plays an essential role in
water permeability and ultrafiltration during peritoneal dialysis. Kidney Int
2006; 1: 1.
4. Asghar RB, Diskin AM, Spanel P et al. Measuring transport of water across
the peritoneal membrane. Kidney Int 2003; 64: 1911–1915.
5. Asghar RB, Diskin AM, Spanel P et al. Influence of convection on the diffusive
transport and sieving of water and small solutes across the peritoneal
membrane. J Am Soc Nephrol 2005; 16: 437–443; e-pub 2004 Dec 29.
6. La Milia V, Di Filippo S, Crepaldi M et al. Mini-peritoneal equilibration test:
a simple and fast method to assess free water and small solute transport
across the peritoneal membrane. Kidney Int 2005; 68: 840–846.
7. Parikova A, Smit W, Struijk DG et al. The contribution of free water
transport and small pore transport to the total fluid removal in peritoneal
dialysis. Kidney Int 2005; 68: 1849–1856.
8. Parikova A, Smit W, Struijk DG et al. Analysis of fluid transport pathways
and their determinants in peritoneal dialysis patients with ultrafiltration
failure. Kidney Int 2006; 70: 1988–1994; e-pub 2006 Oct 11.
9. Venturoli D, Rippe B. Validation by computer simulation of two indirect
methods for quantification of free water transport in peritoneal dialysis.
Perit Dial Int 2005; 25: 77–84.
10. Sobiecka D, Waniewski J, Werynski A et al. Peritoneal fluid transport in
CAPD patients with different transport rates of small solutes. Perit Dial Int
2004; 24: 240–251.
11. Goffin E, Combet S, Jamar F et al. Expression of aquaporin-1 in a long-
term peritoneal dialysis patient with impaired transcellular water
transport. Am J Kidney Dis 1999; 33: 383–388.
12. Krediet RT. The effective lymphatic absorption rate is an accurate and
useful concept in the physiology of peritoneal dialysis. Perit Dial Int 2004;
24: 309–313; discussion 316–307.
13. Flessner M. Effective lymphatic absorption rate is not a useful or accurate
term to use in the physiology of peritoneal dialysis. Perit Dial Int 2004; 24:
313–316; discussion 316–317.
14. Michels WM, Zweers MM, Smit W et al. Does lymphatic absorption
change with the duration of peritoneal dialysis? Perit Dial Int 2004; 24:
347–352.
15. Stachowska-Pietka J, Waniewski J, Flessner MF et al. Distributed model of
peritoneal fluid absorption. Am J Physiol Heart Circ Physiol 2006; 291:
H1862–H1874; e-pub 2006 May 19.
16. Flessner MF, Dedrick RL, Schultz JS. A distributed model of peritoneal-
plasma transport: theoretical considerations. Am J Physiol 1984; 246:
R597–R607.
17. Ronco C, Brendolan A, Crepaldi C et al. Ultrafiltration and clearance
studies in human isolated peritoneal vascular loops. Blood Purif 1994; 12:
233–242.
18. Ronco C. The ‘nearest capillary’ hypothesis: a novel approach to
peritoneal transport physiology. Perit Dial Int 1996; 16: 121–125.
19. Ronco C, Feriani M, Chiaramonte S et al. Peritoneal blood flow: does it
matter? Perit Dial Int 1996; 16: S70–S75.
20. Zakaria ER, Rippe B. Intraperitoneal fluid volume changes during
peritoneal dialysis in the rat: indicator dilution vs volumetric
measurements. Blood Purif 1995; 13: 255–270.
21. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ et al. Peritoneal
transport characteristics with glucose polymer based dialysate. Kidney Int
1996; 50: 979–986.
22. Wolfson M, Piraino B, Hamburger RJ et al. A randomized controlled trial to
evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J
Kidney Dis 2002; 40: 1055–1065.
23. Freida P, Galach M, Filho JC et al. Combination of crystalloid (glucose) and
colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid
and solute transport during the long Pd dwell. Perit Dial Int 2007; 27:
267–276.
24. Lindholm B, Heimbu¨rger O, Waniewski J et al. Peritoneal ultrafiltration
and fluid reabsorption during peritoneal dialysis. Nephrol Dial Transplant
1989; 4: 805–813.
25. De Paepe M, Kips J, Belpaire FM et al. Comparison of Different
Volume Markers in Peritoneal Dialysis. Field, Rich and Associates:
New York, 1986.
26. Stelin G, Rippe B. A phenomenological interpretation of the variation
in dialysate volume with dwell time in CAPD. Kidney Int 1990; 38:
465–472.
27. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid
transport in CAPD. Kidney Int 1991; 40: 315–325.
28. Krediet R, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane
failure. Perit Dial Int 2000; 20: S22–S42.
Kidney International (2008) 73, 1048–1053 1053
RB Asghar and SJ Davies: Pathways of peritoneal reabsorption o r i g i n a l a r t i c l e
